- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Bamco Inc. NY Takes $41.65 Million Position in Heartflow, Inc.
The investment firm purchased over 1.2 million shares of the medical technology company.
Mar. 16, 2026 at 8:19am
Got story updates? Submit your updates here. ›
Bamco Inc. NY, an investment management firm, has purchased a new stake in Heartflow, Inc. (NASDAQ:HTFL), acquiring 1,237,506 shares of the company's stock valued at approximately $41.65 million. This represents about 1.45% ownership of Heartflow at the end of the third quarter.
Why it matters
The investment by Bamco Inc. NY, a prominent institutional investor, in Heartflow, a medical technology company focused on non-invasive diagnostic solutions for coronary artery disease, signals confidence in the company's potential and technology. This could help boost Heartflow's visibility and access to capital as it continues to develop and commercialize its products.
The details
According to a recent SEC filing, Bamco Inc. NY purchased the new stake in Heartflow during the third quarter of the year. The investment firm now owns approximately 1.45% of Heartflow's outstanding shares. Several other major institutional investors, including Wellington Management Group, Baillie Gifford & Co., and Vanguard Group, have also added to or reduced their stakes in Heartflow in recent quarters.
- Bamco Inc. NY purchased the new stake in Heartflow during the 3rd quarter of the year.
- The filing disclosing the investment was made on March 16, 2026.
The players
Bamco Inc. NY
An investment management firm that has purchased a new stake in Heartflow, Inc.
Heartflow, Inc.
A medical technology company that develops non-invasive diagnostic solutions for coronary artery disease.
The takeaway
Bamco Inc. NY's investment in Heartflow, a prominent medical technology company, suggests institutional confidence in Heartflow's products and potential. This could help the company access additional capital and resources as it continues to develop and commercialize its non-invasive diagnostic solutions for coronary artery disease.
New York top stories
New York events
Mar. 16, 2026
The Banksy Museum New York!Mar. 16, 2026
Banksy Museum - FlexiticketMar. 16, 2026
The Banksy Museum New York!



